window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Drug Development,Partnerships & Funding,Patient Centricity,Precision medicine

    Cinclus Pharma signs €220m Europe deal with Zentiva for GERD drug

    Cinclus Pharma has partnered with Zentiva to commercialize and manufacture [...]

    May 22, 2025
  • Artificial Intelligence,Drug Development

    Pharma’s innovation blind spot: Why speed and business model agility will define the next decade

    Pharmaceutical innovation is at a critical inflection point. Most companies [...]

    May 22, 2025
  • Clinical Trials,Drug Development,Patient Centricity

    myTomorrows tops 15,000 global patient matches for pre-approval treatment access

    Clinical trial platform’s AI and navigator-led model bridges gap in [...]

    May 20, 2025
  • Clinical Trials,Patient Centricity

    Flexibility and precision: How Phastar is driving innovation in clinical trials

    As the pharmaceutical industry marks World Clinical Trials Day 2025, [...]

    May 21, 2025
  • Clinical Trials,Drug Development,Patient Centricity

    Patient priorities must shape trial design, says One2Treat lead

    To mark Clinical Trials Day, Discover Pharma speaks with Tom [...]

    May 20, 2025
  • Clinical Trials,Drug Development,Women in Pharma

    Fixing the gender gap in clinical trials

    Dr Anita Phung, GP and medical monitor at Lindus Health, [...]

    May 20, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Regulatory Affairs

    Yseop on FDA’s AI push: Why structured, explainable content is the future of regulatory submissions

    As the FDA accelerates its use of generative AI in [...]

    May 19, 2025
  • Artificial Intelligence,Clinical Trials

    PhaseV raises $50M to expand AI-powered clinical trial platform

    PhaseV has secured $50 million in Series A funding to [...]

    May 13, 2025
  • Clinical Trials,Drug Development

    FTD trial milestone reached as Vesper Bio enrols first asymptomatic GRN carriers

    Vesper Bio has reached a key enrolment milestone in its [...]

    May 12, 2025
  • Movers & Shakers

    New CEO to supercharge US expansion: Clean Biologics hires life sciences heavyweight

    Clean Biologics has appointed Laurent Claisse as chief executive officer, [...]

    May 12, 2025
Previous789Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
  • Aravax adds allergy specialists to board as peanut therapy advances
    Categories: Biotech, Clinical Development, Clinical Trials, Healthcare leadership, Immunology, Movers & Shakers
  • AI-derived drug candidate reduces fentanyl intake in preclinical opioid study
    Categories: Artificial Intelligence, Clinical studies, Drug discovery, Neurosciences, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top